Clinical Trials Directory

Trials / Unknown

UnknownNCT02012517

Antibiotic Prophylaxis in Prosthetic Breast Reconstructions

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The added benefit of prolonged antibiotic prophylactic treatment in patients undergoing breast reconstruction who have drains placed for several days after surgery is controversial. In this study we aim to compare two prophylactic regimens: 1. 24 hour antibiotic treatment prior to surgery with cefazolin 2. a prolonged antibiotic regimen consisting of 48 hours cefazolin treatment followed by oral therapy with cephalexin until the removal of the drains. Patients will sign an informed consent form prior to the surgery and will be randomized to one of the antibiotic regimens. Patients will be closely followed up to one year after surgery. The number of surgical site infections according to the NNIS criteria and loss of breast implants will be compared between the two groups.

Conditions

Interventions

TypeNameDescription
DRUGProlonged antibiotic treatment
DRUGShort antibiotic course (standard of care)

Timeline

Start date
2014-01-01
Primary completion
2016-12-01
Completion
2017-12-01
First posted
2013-12-16
Last updated
2013-12-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02012517. Inclusion in this directory is not an endorsement.